Physician Dispensed Cosmeceuticals: A Global Strategic Business Report
San Jose, CA (PRWEB) July 12, 2012
Follow us on LinkedIn – The beauty and skin care markets are packed with new options entering the scene each year. The products claim to enhance an individual’s appearance and range from simple over-the-counter topical creams to plastic surgery at the extreme. Despite the rising popularity of surgical procedures, many consumers still prefer minimally invasive substitutes which impart enhanced results. However, the efficacy of most topical applications available at retail counters is limited due to their inability to pass the skin barrier, while systemic applications have potential side effects.
In comparison to the available branded retail products, physician dispensed cosmeceuticals connote a high-perceived value in consumer mindsets, owing to their ability to enhance appeal of skin that suits the consumers’ varied lifestyle requirements. Consumers are increasingly wooed by the functionality of these products in effectively managing their beauty and skin care needs without adversely impacting their skin health in different work and leisure milieus. Though manufacturer profitability continues to vest on sustained success of their existing product offerings, companies are increasingly investing in research development of new products to stay competitive. Growth in the market is further expected to be driven by recovery in global economies which would help pep up consumer spending on cosmeceutical products. Another factor expected to bring improvement in sales is increasing number of dispensing physicians each year. Besides, deepening Internet penetration and use of e-commerce platform as a marketing channel by manufacturers is expected to drive future sales.
Traditional aesthetic practitioners, including dermatologists and plastic surgeons comprise the core customer base for manufacturers of physician dispensed cosmeceuticals. However, companies are increasingly seeking expansion into non-core physician specialties such as family practitioners, obstetricians and gynecologists, and general surgeons. Physician-directed medi-spas and non-medical day spas are also being sought as potential growth avenues by manufacturers. Further, higher awareness levels regarding the need to condition the skin before and after cosmetic treatments is encouraging the launch of numerous new lines of physician dispensed skin care products. In particular, skin care products for wound healing post procedures, such as chemical peels and laser resurfacing, are growing in demand.
Product innovation stands out as the key strategy for companies to survive competition in the cosmeceuticals space. To remain competitive, companies are increasingly focusing on innovative ingredients that offer improved and visible outcomes. Besides organic formulations, manufacturers of cosmetic products are displaying greater interest in science-based products. The industry is witnessing the inclusion of novel active ingredients such as the human growth factors and peptides that stimulate collagen production and promote healing of damaged skin. Delivery of peptides into the skin is a compelling area of interest in cosmetic science as peptides when delivered into the skin perform several skin functions. Another emerging ingredient category of interest is skin growth factors and ingredients that stimulate the skin to produce them.
Geographically, the US represents the single largest market worldwide, as stated by the new market research report on Physician Dispensed Cosmeceuticals. Physician-dispensed cosmeceutical market in the US is expected to be significantly boosted by the high aesthetic attentiveness among the consumers. The market is increasingly witnessing new physician specialties, more specifically, general practitioners entering the cosmeceutical space to seek greater profit margins. Asia-Pacific is projected to register the fastest CAGR over the analysis period. Segment-wise, physician dispensed skin-care products comprises the largest segment. On the other hand, physician dispensed eyelash products represent the fastest growing segment, projected to grow at a compounded annual rate of 18.5% through 2018.
The physician dispensed cosmeceuticals market is highly competitive, and manufacturing companies rely on the development of novel components in order to retain their viability and promote product penetration amid consumers and physicians. Major players profiled in the report include Allergan, Athena Cosmetics, Jan Marini Skin Research, Candem Pharma, Clinique Laboratories, exCel Manufacturing Co., La Roche-Posay Laboratoire Pharmaceutique, Neutrogena Corporation, Obagi Medical Products, Pacific Bioscience Laboratories, SkinCeuticals, SkinMedica, Stiefel Laboratories, among others.
The research report titled "Physician Dispensed Cosmeceuticals: A Global Strategic Business Report" announced by Global Industry Analysts, Inc., provides a comprehensive review of trends, issues, strategic industry activities, and profiles of major companies worldwide. The report provides market estimates and projections (US$ Million) for global and regional markets including the US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World. Key Product segments analyzed include Eyelash Products and Skin Care Products.
For more details about this comprehensive market research report, please visit –
About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a leading publisher of off-the-shelf market research. Founded in 1987, the company currently employs over 800 people worldwide. Annually, GIA publishes more than 1300 full-scale research reports and analyzes 40,000+ market and technology trends while monitoring more than 126,000 Companies worldwide. Serving over 9500 clients in 27 countries, GIA is recognized today, as one of the world's largest and reputed market research firms.
Global Industry Analysts, Inc.
Web Site: http://www.StrategyR.com/